Cargando…
Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015
BACKGROUND: In response to increasing resistance to anti-malarial drugs, Senegal adopted artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated malaria in 2006. However, resistance of Plasmodium falciparum parasites to artemisinin derivatives, characterized by dela...
Autores principales: | Diawara, Silman, Madamet, Marylin, Kounta, Mame Bou, Lo, Gora, Wade, Khalifa Ababacar, Nakoulima, Aminata, Bercion, Raymond, Amalvict, Rémy, Gueye, Mamadou Wague, Fall, Bécaye, Diatta, Bakary, Pradines, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356232/ https://www.ncbi.nlm.nih.gov/pubmed/28302108 http://dx.doi.org/10.1186/s12936-017-1773-4 |
Ejemplares similares
-
Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014
por: Fall, Bécaye, et al.
Publicado: (2016) -
Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014
por: Boussaroque, Agathe, et al.
Publicado: (2016) -
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013
por: Torrentino-Madamet, Marylin, et al.
Publicado: (2014) -
Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013–2014 malaria season
por: Fall, Bécaye, et al.
Publicado: (2015) -
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal
por: Wurtz, Nathalie, et al.
Publicado: (2012)